DCN and bronchopulmonary dysplasia: The 20% survival rate of BPD rats increased to 70% after treatment with MSCs, to 80% after treatment with scrambled control siRNA-transfected MSCs, and to 40% after treatment with decorin siRNA-transfected MSCs (Figure 5a).